• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈癌疼痛的类型与成因

Types and causes of pain in cancer of the head and neck.

作者信息

Vecht C J, Hoff A M, Kansen P J, de Boer M F, Bosch D A

机构信息

Department of Neurology, Dr. Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.

出版信息

Cancer. 1992 Jul 1;70(1):178-84. doi: 10.1002/1097-0142(19920701)70:1<178::aid-cncr2820700128>3.0.co;2-e.

DOI:10.1002/1097-0142(19920701)70:1<178::aid-cncr2820700128>3.0.co;2-e
PMID:1606540
Abstract

In a series of 25 patients with head and neck cancer who had severe pain, the type and cause of the pain were analyzed. There were two types of pain: nociceptive and non-nociceptive. Nineteen (76%) patients had nociceptive pain that could be subdivided into actual nociceptive pain (9 patients), nociceptive nerve pain (8 patients), or referred pain (2 patients). The cause of nociceptive pain was secondary to tumor recurrence in 16 patients and secondary to benign inflammation in 3 patients. Of the six (23%) cases of non-nociceptive pain, all were diagnosed as neuropathic pain secondary to the sequels of neck dissection. World Health Organization guidelines were applied for the treatment of symptomatic pain of nociceptive pain; if necessary, nerve blocks were used after this treatment. Non-nociceptive pain was usually treated with amitriptyline or carbamazepine. If tumor recurrence was the cause of the pain, antitumor-directed therapy was applied, when possible. Relief was achieved in 52% of the patients after two attempts to treat pain, in 64% after three attempts, and in up to 72% after four attempts. Pain could not be controlled in 28% of the patients. Patients with tumor recurrence had a short median survival time of 3 months, regardless of pain control. Patients with neuropathic pain had a survival time of 16 months or more (median not reached). The authors conclude that the type and cause of the pain in cancer of the head and neck can be determined; this can lead to the administration of proper symptomatic therapy or treatment directed at the underlying cause. In most cases, several successive attempts to treat pain were made before relief was achieved.

摘要

在一系列25例患有严重疼痛的头颈癌患者中,对疼痛的类型和原因进行了分析。疼痛有两种类型:伤害感受性疼痛和非伤害感受性疼痛。19例(76%)患者有伤害感受性疼痛,可细分为实际伤害感受性疼痛(9例)、伤害感受性神经痛(8例)或牵涉痛(2例)。伤害感受性疼痛的原因在16例患者中是继发于肿瘤复发,3例患者中是继发于良性炎症。在6例(23%)非伤害感受性疼痛病例中,均被诊断为颈部清扫术后后遗症继发的神经性疼痛。应用世界卫生组织的指南来治疗伤害感受性疼痛的症状性疼痛;如有必要,在该治疗后使用神经阻滞。非伤害感受性疼痛通常用阿米替林或卡马西平治疗。如果肿瘤复发是疼痛的原因,则尽可能应用针对肿瘤的治疗。在两次尝试治疗疼痛后,52%的患者疼痛得到缓解,三次尝试后为64%,四次尝试后高达72%。28%的患者疼痛无法得到控制。无论疼痛是否得到控制,肿瘤复发的患者中位生存时间较短,为3个月。神经性疼痛的患者生存时间为16个月或更长(未达到中位值)。作者得出结论,头颈癌疼痛的类型和原因可以确定;这可以导致给予适当的对症治疗或针对潜在病因的治疗。在大多数情况下,在疼痛得到缓解之前进行了几次连续的疼痛治疗尝试。

相似文献

1
Types and causes of pain in cancer of the head and neck.头颈癌疼痛的类型与成因
Cancer. 1992 Jul 1;70(1):178-84. doi: 10.1002/1097-0142(19920701)70:1<178::aid-cncr2820700128>3.0.co;2-e.
2
Difficult problems and their solutions in patients with cancer pain of the head and neck areas.
Curr Rev Pain. 2000;4(3):206-14. doi: 10.1007/s11916-000-0081-8.
3
Validation of World Health Organization guidelines for pain relief in head and neck cancer. A prospective study.世界卫生组织头颈部癌疼痛缓解指南的验证:一项前瞻性研究
Ann Otol Rhinol Laryngol. 1993 May;102(5):342-8. doi: 10.1177/000348949310200504.
4
Neuropathic and nociceptive pain in head and neck cancer patients receiving radiation therapy.接受放射治疗的头颈癌患者的神经性疼痛和伤害感受性疼痛。
Head Neck Oncol. 2009 Jul 14;1:26. doi: 10.1186/1758-3284-1-26.
5
Pain experienced by patients with terminal head and neck carcinoma.晚期头颈癌患者所经历的疼痛。
Cancer. 1997 Sep 15;80(6):1117-23.
6
Pain control in advanced and recurrent head and neck cancer.
Otolaryngol Clin North Am. 1980;13(3):551-60.
7
Management of somatic pain induced by head-and-neck cancer treatment: definition and assessment. Guidelines of the French Oto-Rhino-Laryngology- Head and Neck Surgery Society (SFORL).头颈部癌症治疗引起的躯体疼痛的管理:定义与评估。法国耳鼻咽喉头颈外科学会(SFORL)指南
Eur Ann Otorhinolaryngol Head Neck Dis. 2014 Sep;131(4):243-7. doi: 10.1016/j.anorl.2014.07.003. Epub 2014 Aug 6.
8
Topical morphine gel for pain management in head and neck cancer patients.局部用吗啡凝胶用于头颈部癌症患者的疼痛管理
Auris Nasus Larynx. 2014 Oct;41(5):496-8. doi: 10.1016/j.anl.2014.05.016. Epub 2014 Jun 12.
9
Pain and loss of function in head and neck cancer survivors.头颈癌幸存者的疼痛与功能丧失
J Pain Symptom Manage. 1999 Sep;18(3):193-202. doi: 10.1016/s0885-3924(99)00070-6.
10
Oral cancer pain.口腔癌痛。
Oral Oncol. 2010 Jun;46(6):448-51. doi: 10.1016/j.oraloncology.2010.02.017. Epub 2010 Mar 21.

引用本文的文献

1
A Scoping Review of Clinical Features and Mechanisms of Orofacial Pain and Headache in Patients with Head and Neck Cancer.头颈部癌症患者口面部疼痛和头痛的临床特征及机制的范围综述
J Clin Med. 2025 Aug 13;14(16):5722. doi: 10.3390/jcm14165722.
2
Cancer-related pain in head and neck cancer survivors: longitudinal findings from the Head and Neck 5000 clinical cohort.头颈癌幸存者的癌症相关疼痛:来自头颈5000临床队列的纵向研究结果
J Cancer Surviv. 2024 Feb 29. doi: 10.1007/s11764-024-01554-x.
3
The 3D's of Neural Phenotypes in Oral Cancer: Distance, Diameter, and Density.
口腔癌神经表型的 3D:距离、直径和密度。
Adv Biol (Weinh). 2023 Feb;7(2):e2200188. doi: 10.1002/adbi.202200188. Epub 2022 Nov 14.
4
Factors associated with adherence to guidelines in cancer pain management among adult patients evaluated at oncology unit, in the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia.在埃塞俄比亚西北部贡德尔大学综合专科医院肿瘤科室接受评估的成年癌症疼痛管理患者中,与指南依从性相关的因素。
Front Pain Res (Lausanne). 2022 Aug 1;3:884253. doi: 10.3389/fpain.2022.884253. eCollection 2022.
5
Treatment of Neuropathic Pain Directly Due to Cancer: An Update.癌症直接导致的神经性疼痛的治疗:最新进展
Cancers (Basel). 2022 Apr 14;14(8):1992. doi: 10.3390/cancers14081992.
6
Head and neck cancer survivors' pain in France: the VICAN study.法国头颈部癌症幸存者的疼痛:VICAN 研究。
J Cancer Surviv. 2022 Feb;16(1):119-131. doi: 10.1007/s11764-021-01010-0. Epub 2021 Feb 26.
7
Cervical plexus as anatomical target for the treatment of postoperative cervical neuropathic pain.
J Pain Res. 2019 Apr 16;12:1217-1221. doi: 10.2147/JPR.S184306. eCollection 2019.
8
Evidence-based Clinical Practice Guidelines for Interventional Pain Management in Cancer Pain.癌症疼痛介入性疼痛管理的循证临床实践指南
Indian J Palliat Care. 2015 May-Aug;21(2):137-47. doi: 10.4103/0973-1075.156466.
9
Relationship of inflammatory markers and pain in patients with head and neck cancer prior to anticancer therapy.抗癌治疗前头颈癌患者炎症标志物与疼痛的关系。
Braz J Med Biol Res. 2014 Jul;47(7):600-4. doi: 10.1590/1414-431x20143599. Epub 2014 May 30.
10
Prevalence of acute neuropathic pain after cancer surgery: A prospective study.癌症手术后急性神经性疼痛的患病率:一项前瞻性研究。
Indian J Anaesth. 2014 Jan;58(1):36-42. doi: 10.4103/0019-5049.126788.